Cargando…
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
The aim of this study was to investigate the effect of recombinant human endostatin (rh-Endo) in combination with radiation therapy (RT) on esophageal squamous cell carcinoma (ESCC) and explore the potential mechanisms. ECA109-bearing nude mice were administered RT and/or rh-Endo treatment. Tumor vo...
Autores principales: | Zhu, Hongcheng, Yang, Xi, Ding, Yuqiong, Liu, Jia, Lu, Jing, Zhan, Liangliang, Qin, Qin, Zhang, Hao, Chen, Xiaochen, Yang, Yuehua, Yang, Yan, Liu, Zheming, Yang, Meiling, Zhou, Xifa, Cheng, Hongyan, Sun, Xinchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585975/ https://www.ncbi.nlm.nih.gov/pubmed/26412785 http://dx.doi.org/10.1038/srep14503 |
Ejemplares similares
-
Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
por: Li, Wei, et al.
Publicado: (2016) -
Polymorphisms in XPD Gene Could Predict Clinical Outcome of Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer Patients: A Meta-Analysis of 24 Studies
por: Qin, Qin, et al.
Publicado: (2013) -
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G(2) checkpoint and suppression of homologous recombination repair
por: Qin, Qin, et al.
Publicado: (2014) -
Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2022) -
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2017)